Farajnia Safar, Alikhani Mohammad Yousef, Ghotaslou Reza, Naghili Behrooz, Nakhlband Ailar
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Int J Infect Dis. 2009 Mar;13(2):140-4. doi: 10.1016/j.ijid.2008.04.014. Epub 2008 Aug 13.
The empirical therapy of urinary tract infections (UTI) relies on the predictability of the agents causing UTI and knowledge of their antimicrobial susceptibility patterns.
In a prospective study undertaken over a 14-month period, 5136 samples from patients suspected of having a UTI were analyzed, of which 676 were culture-positive. Isolated bacteria were identified by standard tests, and antibiotic susceptibility was determined by disk diffusion method.
According to our results, Escherichia coli was the most common etiological agent of UTI (74.6%), followed by Klebsiella spp (11.7%), Staphylococcus saprophyticus (6.4%), and Pseudomonas aeruginosa (2.2%). Analysis of the frequency of isolated bacteria according to the age of the patients revealed that Klebsiella infections are more prevalent in the older age groups (>10 years) and Pseudomonas infections are more prevalent in children and the elderly (<9 years and >60 years). Results of antimicrobial susceptibility analysis for E. coli, as the most prevalent cause of UTI, to commonly used antibiotics are as follows: amikacin (97.8%), gentamicin (97%), ciprofloxacin (94%), nitrofurantoin (87.1%), nalidixic acid (93.7%), trimethoprim-sulfamethoxazole (48.2%), cephalexin (76%), and ampicillin (6.9%).
The results show that the antimicrobial resistance patterns of the causes of UTI are highly variable and continuous surveillance of trends in resistance patterns of uropathogens is important.
尿路感染(UTI)的经验性治疗依赖于引起UTI的病原体的可预测性及其抗菌药敏模式的知识。
在一项为期14个月的前瞻性研究中,对5136份疑似UTI患者的样本进行了分析,其中676份培养呈阳性。通过标准试验鉴定分离出的细菌,并采用纸片扩散法测定抗生素敏感性。
根据我们的结果,大肠杆菌是UTI最常见的病原体(74.6%),其次是克雷伯菌属(11.7%)、腐生葡萄球菌(6.4%)和铜绿假单胞菌(2.2%)。根据患者年龄分析分离细菌的频率显示,克雷伯菌感染在老年组(>10岁)中更为普遍,而铜绿假单胞菌感染在儿童和老年人(<9岁和>60岁)中更为普遍。作为UTI最常见病因的大肠杆菌对常用抗生素的药敏分析结果如下:阿米卡星(97.8%)、庆大霉素(97%)、环丙沙星(94%)、呋喃妥因(87.1%)、萘啶酸(93.7%)、甲氧苄啶-磺胺甲恶唑(48.2%)、头孢氨苄(76%)和氨苄西林(6.9%)。
结果表明,UTI病原体的抗菌耐药模式高度可变,持续监测尿路病原体耐药模式的趋势很重要。